Una comparación directa averigua cuáles medicamentos para la diabetes son los mejores para el corazón
MARTES, 9 de mayo de 2023 (HealthDay News) — Hay muchos medicamentos para la diabetes tipo 2, pero una clase quizá se destaque por proteger al corazón, sugiere un estudio reciente. El estudio, de miles de veteranos de EE. UU. con diabetes, encontró q…
Learn MoreHead-to-Head Study Finds Which Diabetes Meds Are Best for the Heart
TUESDAY, May 9, 2023 (HealthDay News) — There are many medications for type 2 diabetes, but one class may stand out for protecting the heart, a new study suggests.The study, of thousands of U.S. veterans with diabetes, found that those who added drug…
Learn MoreEmpagliflozin Improves HbA1c in Young People With T2DM
TUESDAY, March 21, 2023 (HealthDay News) — For young people, empagliflozin is associated with improvement in glycated hemoglobin (HbA1c), according to a study published in the March issue of The Lancet Diabetes & Endocrinology.Lori M. Laffel, M.D., f…
Learn MoreEli Lilly reducirá los precios de la insulina, y limitará los costos mensuales de desembolso a 35 dólares
MIÉRCOLES, 1 de marzo de 2023 (HealthDay News) — Pronto, más estadounidenses pagarán menos por la insulina.Eli Lilly, uno de los tres fabricantes de insulina, planifica reducir sus precios de lista del medicamento en un 70 por ciento, y limitar los c…
Learn MoreEli Lilly to Slash Insulin Prices, Cap Monthly Out-of-Pocket Costs at $35
WEDNESDAY, March 1, 2023 (HealthDay News) — More Americans will soon be paying less for their insulin.Eli Lilly, one of the three insulin manufacturers, plans to cut its list prices of the drug by 70% and cap out-of-pocket costs at $35 a month.”While…
Learn MoreToo Few Americans With Diabetes Are Getting Recommended Meds
TUESDAY, Feb. 28, 2023 (HealthDay News) — Most Americans with type 2 diabetes are candidates for newer, pricey medications, but few are getting them, a new government study shows.Researchers found that of U.S. adults with the blood sugar disease, ove…
Learn MoreType 1 Diabetes and Use of ‘Off-Label’ Drugs: Benefits, but Concerns, Too
MONDAY, Feb. 20, 2023 (HealthDay News) — While people with type 1 diabetes can see some benefit from newer medications prescribed off-label, there is also risk, and these patients should be monitored closely, according to a new study.Type 1 diabetes …
Learn MoreEscasea Ozempic, un fármaco para la diabetes que los estadounidenses están usando para perder peso
MIÉRCOLES, 21 de diciembre de 2022 (HealthDay News) — Elon Musk es fan del medicamento para perder peso Wegovy, y se rumorea que Kim Kardashian lo ha usado para perder 16 libras (7 kilos) en tres semanas para caber en el vestido retro que una vez usa…
Learn More